Malignancies, Prothrombotic Mutations, and the Risk of Venous Thrombosis
Top Cited Papers
Open Access
- 9 February 2005
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 293 (6) , 715-722
- https://doi.org/10.1001/jama.293.6.715
Abstract
In 1868, Trousseau described the relationship between malignancy and venous thrombosis.1 Recent studies showed a 4% to 20% prevalence of malignancy in patients with deep venous thrombosis or pulmonary embolism.2,3 Although the risk of venous thrombosis in patients with cancer is evidently increased, studies that identify patients at highest risk of thrombosis are scarce. It is unclear what risks are for various types and stages of cancer.4,5Keywords
This publication has 16 references indexed in Scilit:
- Venous Thrombosis in Patients with Solid Tumors: Determination of Frequency and CharacteristicsThrombosis and Haemostasis, 2002
- Prognosis of Cancers Associated with Venous ThromboembolismNew England Journal of Medicine, 2000
- Rates of Initial and Recurrent Thromboembolic Disease Among Patients with Malignancy Versus Those without Malignancy: Risk Analysis Using Medicare Claims DataMedicine, 1999
- Venous thrombosis: a multicausal diseaseThe Lancet, 1999
- Nontraditional Epidemiologic Approaches in the Analysis of Gene Environment Interaction: Case-Control Studies with No Controls!American Journal of Epidemiology, 1996
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Deep venous thrombosis and occult malignancy: an epidemiological studyBMJ, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- A simple salting out procedure for extracting DNA from human nucleated cellsNucleic Acids Research, 1988
- ON ESTIMATING THE RELATION BETWEEN BLOOD GROUP AND DISEASEAnnals of Human Genetics, 1955